Insomnia Prevention in Children With Acute Lymphoblastic Leukemia

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Dana-Farber Cancer Institute
Study ID
NCT05866887
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
4 Years - 12 Years
Healthy Volunteers
Not accepted

Interventions

  • Sleep ALL Night — BEHAVIORAL
    Sleep intervention program comprised of a sleep action plan tool and interactive psychoeducation website.

Study Details

The goal of this research study is to understand the acceptability and feasibility of the Sleep ALL Night intervention among children with Acute Lymphoblastic Leukemia (ALL) in hopes of improving the discussion of sleep disorders with clinical providers. The name of the intervention used in this research study is: Sleep ALL Night, which is a sleep intervention program comprised of an action plan tool and psychoeducational website.

Key Dates

Start date
Sep 26, 2023
Status verified
May 2025
Primary completion
Jun 5, 2024
Completion
Jun 5, 2024

Study Design

Enrollment
25 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Sleep ALL Night
    Participants and parents will complete study procedures as outlined: * Baseline survey completed by participant parent(s). * Introduction to Sleep ALL Night action plan. * Review of psychoeducational website and completion of sleep diary. * Survey completed by participant parent(s).

Primary Outcome Measure

Enrollment Rate of Participants [ Time Frame: At screening, when eligible participants are approached by research staff. Recruitment occurred over a 5-month period. ]

Locations (2)

FacilityCityStateZIPSite coordinators
Boston Children's HospitalBostonMassachusetts02215-
Dana-Farber Cancer InstituteBostonMassachusetts02215-

Find similar trials in Boston, MA

By condition
Leukemia (other)
By specialty
OncologyBlood cancer
By research site
Boston Children's Hospital· Boston, MADana-Farber Cancer Institute· Boston, MA

Related Studies